Yang; Donglai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yang; Donglai.The latest application filed is for "pharmaceutical formulations of tropomyosin related kinase (trk) inhibitors".

Company Profile

3.17.22

Yang; Donglai - Bridgewater NJ
Yang; Donglai - Annandale NJ
Yang; Donglai - West Lafayette IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Formulations Of Tropomyosin Related Kinase (trk) Inhibitors App 20220110861 - Lieberman; Harvey ; et al.	2022-04-14
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors Grant 11,110,055 - Lieberman , et al. September 7, 2	2021-09-07
Pharmaceutical Formulations Of Tropomyosin Related Kinase (trk) Inhibitors App 20200048222 - Lieberman; Harvey ; et al.	2020-02-13
Pharmaceutical formulations of tropomyosin related kinase (Trk) inhibitors Grant 10,219,998 - Lieberman , et al.	2019-03-05
Pharmaceutical Formulations Of Tropomyosin Related Kinase (trk) Inhibitors App 20180000728 - LIEBERMAN; Harvey ; et al.	2018-01-04
Forms of rifaximin and uses thereof Grant 9,700,545 - Gushurst , et al. July 11, 2	2017-07-11
Forms of rifaximin and uses thereof Grant 9,546,183 - Gushurst , et al. January 17, 2	2017-01-17
Forms Of Rifaximin And Uses Thereof App 20160317507 - Gushurst; Karen S. ; et al.	2016-11-03
Forms Of Rifaximin And Uses Thereof App 20160200738 - Gushurst; Karen S. ; et al.	2016-07-14
Forms of rifaximin and uses thereof Grant 9,359,357 - Gushurst , et al. June 7, 2	2016-06-07
Forms of rifaximin and uses thereof Grant 9,273,066 - Gushurst , et al. March 1, 2	2016-03-01
Forms of rifaximin and uses thereof Grant 9,181,274 - Gushurst , et al. November 10, 2	2015-11-10
Forms Of Rifaximin And Uses Thereof App 20150299199 - Gushurst; Karen S. ; et al.	2015-10-22
Forms of rifaximin and uses thereof Grant 9,034,892 - Gushurst , et al. May 19, 2	2015-05-19
Forms Of Rifaximin And Uses Thereof App 20140179916 - Gushurst; Karen S. ; et al.	2014-06-26
Forms of rifaximin and uses thereof Grant 8,754,098 - Gushurst , et al. June 17, 2	2014-06-17
Forms Of Rifaximin And Uses Thereof App 20140141081 - Gushurst; Karen S. ; et al.	2014-05-22
Forms Of Rifaximin And Uses Thereof App 20140011828 - Gushurst; Karen S. ; et al.	2014-01-09
Forms of rifaximin and uses thereof Grant 8,569,326 - Gushurst , et al. October 29, 2	2013-10-29
Forms of rifaximin and uses thereof Grant 8,486,956 - Gushurst , et al. July 16, 2	2013-07-16
Forms Of Rifaximin And Uses Thereof App 20130066079 - Gushurst; Karen S. ; et al.	2013-03-14
Forms Of Rifaximin And Uses Thereof App 20120316334 - Gushurst; Karen S. ; et al.	2012-12-13
Forms Of Rifaximin And Uses Thereof App 20120076857 - Gushurst; Karen S. ; et al.	2012-03-29
Forms of rifaximin and uses thereof Grant 8,067,429 - Gushurst , et al. November 29, 2	2011-11-29
Salts and Crystal Forms App 20110053997 - Beliaev; Alexander ; et al.	2011-03-03
Forms Of Rifaximin And Uses Thereof App 20100239664 - Gushurst; Karen S. ; et al.	2010-09-23
Forms Of Rifaximin And Uses Thereof App 20100174064 - Gushurst; Karen S. ; et al.	2010-07-08
Crystalline forms of tiagabine hydrochloride App 20080064727 - Childs; Scott L. ; et al.	2008-03-13
Crystalline and amorphous forms of tiagabine App 20080051435 - Childs; Scott L. ; et al.	2008-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.